CVEvulnerability
CVE-2016-8355
9.9 CRITICAL
Official page ↗
- Status
- Modified
- Published
- 2017-02-13
- Last modified
- 2026-06-17
- Assigner
- [email protected]
- CVSS 3.0 ([email protected])
- 9.9 CRITICAL — CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
- CVSS 2.0 ([email protected])
- 9.0 HIGH — AV:N/AC:L/Au:S/C:C/I:C/A:C
- Weaknesses
- CWE-306
Description
An issue was discovered in Smiths-Medical CADD-Solis Medication Safety Software, Version 1.0; 2.0; 3.0; and 3.1. CADD-Solis Medication Safety Software grants an authenticated user elevated privileges on the SQL database, which would allow an authenticated user to modify drug libraries, add and delete users, and change user permissions. According to Smiths-Medical, physical access to the pump is required to install drug library updates.
Affected configurations
• smiths-medical cadd-solis medication safety software 1.0
• smiths-medical cadd-solis medication safety software 2.0
• smiths-medical cadd-solis medication safety software 3.0
• smiths-medical cadd-solis medication safety software 3.1
Related
Weakness · CWE (1)
- CWE-306 Missing Authentication for Critical Functionality weakness
References
- http://www.securityfocus.com/bid/94630 Third Party Advisory, VDB Entry
- https://ics-cert.us-cert.gov/advisories/ICSMA-16-306-01 Third Party Advisory, US Government Resource
- http://www.securityfocus.com/bid/94630 Third Party Advisory, VDB Entry
- https://ics-cert.us-cert.gov/advisories/ICSMA-16-306-01 Third Party Advisory, US Government Resource